BCL2L12 and neoplasm: NU-0129 exhibited prominent tumor accumulation (ranging between 4 × 109 and 1.1 × 1011 particles/g of tumor tissue) (Fig. 2D and E), with 20% of intratumoral SNA being located inside tumor cells, which induced a reduction of tumor-associated Bcl2L12 protein expression.